Enhancing Post-Stroke Dysphagia Rehabilitation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorHamad Medical Corporation

About this trial

The goal of this clinical trial is to investigate the effects of a combined swallowing intervention (Neuromuscular Electrical Stimulation (NMES) + Neuromuscular Taping (NMT) + swallowing exercises) on swallowing function and quality of life in post-stroke dysphagia patients. The main questions it aims to answer are:

• Does the combination of swallowing exercises, NMES \& NMT have a greater improvement in dysphagia rehabilitation when compared to either NMES or NMT alone? Researchers will compare the effects of intervention between the three groups (NMES and swallowing exercises, NMT and swallowing exercises, and NMES with NMT and swallowing exercises).

Participants will:

* Receive a combined dysphagia rehabilitation comprised of swallowing exercises, Neuromuscular Electrical stimulation, and/or Neuromuscular Taping. * Visit the clinic once every 5 days a week for 10 therapy sessions. * Undergo baseline and post-intervention evaluation procedures.

Eligibility criteria

Qualifiers

Patients aged 18 - 75 years old,

Diagnosed with swallowing disorders between one day and six months post-stroke,

Able to attend 10 therapy sessions,

Have never received any swallowing treatment before participating in this study.

Disqualifiers

Post-stroke patients with severe cognitive impairment,

Patients who have swallowing disorders due to other etiologies,

Patients who need traditional swallowing therapy other than Expiratory Muscle Strength Training (EMST) and Chin Tuck Against Resistance (CTAR). - Skin disorders in the submental area and anterior neck,

Medical conditions that may affect participation,

Trial design

Treatments tested in this trial

  • Neuromuscular Electrical Stimulation
  • Neuromuscular Taping
  • Swallowing exercise (Expiratory Muscle Strength Training)
  • Swallowing exercise (Chin Tuck Against Resistance)

Treatment groups

10 Participants
are divided into 3 treatment groups

Sponsors and collaborators